Breast cancer patients with dense breast tissue more likely to develop contralateral disease

February 7, 2017, University of Texas M. D. Anderson Cancer Center
breast cancer
Mammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public Domain

Breast cancer patients with dense breast tissue have almost a two-fold increased risk of developing disease in the contralateral breast, according to new research from The University of Texas MD Anderson Cancer.

The study, published in the journal Cancer, is among the first to find the association between breast density (BD) and contralateral (CBC).

According to study author Isabelle Bedrosian, M.D., a big challenge in the management of this patient population, especially as they are making surgical decisions, is trying to counsel women appropriately on their risk of developing breast cancer in the other breast.

"We know there are a number of well-established influences for developing both primary and secondary breast cancers, such as BRCA mutations, family history, and the tumor's estrogen receptor status," explained Bedrosian, associate professor, Breast Surgical Oncology. "We also know density is a risk factor for the development of primary breast cancer. However, no one has closely looked at it as a risk factor for developing contralateral disease."

The estimated 10-year risk for women with breast cancer developing CBC can be as low as 2 percent, and as high 40 percent, said Bedrosian. The dramatic range is due in large part to the variability of risk factors across the patient population, she explained.

For the retrospective, case-controlled study, the researchers identified 680 stage I, II and III , all treated at MD Anderson between 1997 and 2012. BRCA patients were excluded from the study, given their known of CBC.

Women with an additional diagnosis of metachronous CBC - defined as BC in the opposite breast diagnosed more than six months after the initial diagnosis - were the "cases," and patients who had not developed CBC were the "controls." Cases and controls were matched on a 1:2 ratio based on a number of factors, including age, year of diagnosis and hormone receptor status.

"With our research, we wanted to evaluate the relationship between the mammographic breast density of the original disease and the development of metachronous breast cancer," said Carlos Barcenas, M.D., assistant professor, Breast Medical Oncology, and the study's corresponding author.

Of the selected patients, 229 were cases and 451 were controls. The MD Anderson researchers categorized each patient's breast density by mammogram reading, assessed at the time of first diagnosis, as "nondense" or "dense," using the categorizations from the American College of Radiology.

Among the cases, 39.3 percent were classified as having nondense and 60.7 percent as having dense breast tissue, compared to 48.3 percent and 51.7 percent, respectively, in the controls.

After adjusting for known factors, the researchers found almost a two-fold increased risk of developing CBC in with dense breasts.

"Our findings have valuable implications for both newly diagnosed patients with dense breasts and for breast cancer survivors as we manage their long-term risk of a secondary diagnosis," said Barcenas. "Our future goal is to develop a risk model incorporating to best assess a breast cancer survivor's risk of developing CBC."

In the long-term, the researchers hope to use this tool to counsel on their personal risk and their options for treatment and surveillance, if their risk is sufficiently high.

Explore further: Most women unaware of breast density's effect on cancer risk, study finds

Related Stories

Most women unaware of breast density's effect on cancer risk, study finds

November 21, 2016
Most women don't know that having dense breasts increases their risk for breast cancer and reduces a mammogram's ability to detect cancer, according to a University of Virginia School of Medicine study.

Breast density research edges closer to cancer prevention

January 24, 2017
Adelaide researchers are one step closer to breast cancer prevention after finding a new driver for breast density, an identified risk factor for breast cancer.

Surgical options after a cancer diagnosis in one breast

November 9, 2016
Dear Mayo Clinic: My daughter was diagnosed with breast cancer at 54 and had surgery to remove one breast. Her surgeon told her that it wasn't necessary to remove both breasts, because she was not at high risk for developing ...

Low breast density in mammography worsens breast cancer prognosis

March 12, 2015
Very low mammographic breast density worsens the prognosis of breast cancer, according to a recent study from the University of Eastern Finland. Disease free survivals as well as overall life expectancies were significantly ...

Breast cancer awareness: What women need to know

September 28, 2016
As national Breast Cancer Awareness Months begins next week, breast health expert Dr. Sharon Koehler of New York Institute of Technology College of Osteopathic Medicine, says women need to know the following five things:

Study suggests breast density alone not a risk factor for cancer

December 2, 2015
Breast density may not be a strong independent factor for breast cancer risk, according to a new study presented today at the annual meeting of the Radiological Society of North America (RSNA).

Recommended for you

Scientists reveal likely cause of childhood leukaemia

May 21, 2018
A major new analysis reveals for the first time the likely cause of most cases of childhood leukaemia, following more than a century of controversy about its origins.

Ice cream funds research showing new strategy against thyroid cancer

May 21, 2018
Anaplastic thyroid cancer is almost uniformly fatal, with an average lifespan of about 5 months after diagnosis. And standard treatment for the condition includes 7 weeks of radiation, often along with chemotherapy.

Bladder cancer model could pave the way for better drug efficacy studies

May 21, 2018
Understanding that not all bladder cancers are the same, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have created a tool that may help them to uncover why only a fraction of patients ...

MR spectroscopy imaging reveals effects of targeted treatment of mutant IDH1 gliomas

May 18, 2018
Using a novel imaging method, a Massachusetts General Hospital (MGH) research team is investigating the mechanisms behind a potential targeted treatment for a subtype of the deadly brains tumors called gliomas. In their report ...

Particle shows promise to prevent the spread of triple-negative breast cancer

May 18, 2018
USC researchers have pinpointed a remedy to prevent the spread of triple-negative breast cancer. Metastatic breast cancer is a leading cause of death for women. The findings appear today in Nature Communications.

Dilemma for cancer patients as life-saving meds are tied to vision loss

May 18, 2018
(HealthDay)—A newer type of cancer treatment may offer the chance of longer survival, but the drugs could also trigger new side effects, such as vision problems.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.